search for




 

Case Report
Successful Treatment of Severe Hemolytic Disease of the Newborn Caused by Anti-Jkb
Clin Pediatr Hematol Oncol 2021;28:49-53.
Published online April 30, 2021
© 2021 Korean Society of Pediatric Hematology-Oncology

Goo Lyeon Kim1, Yoonsoo Kim1, Young Pyo Chang1,2, Ju-Hee Seo1,2 and Mee Jeong Lee1,2

Department of Pediatrics, 1Dankook University Hospital, 2Dankook University College of Medicine, Cheonan, Korea
Correspondence to: Mee Jeong Lee
Department of Pediatrics, Dankook University Hospital, Dankook University College of Medicine, 119, Dandae-ro, Dongnam-gu, Cheonan 31116, Korea
Tel: +82-41-550-3949
Fax: +82-41-559-7940
E-mail: LMJPED@daum.net
ORCID ID: orcid.org/0000-0002-7504-1232
Received March 2, 2021; Revised April 15, 2021; Accepted April 20, 2021.
Abstract
Hemolytic disease of the newborn (HDN) is a condition in which maternal antibodies cross the placenta and cause hemolytic reactions. Anti-RhD was the most common cause, but with the introduction of immunoglobulin, the frequency has decreased significantly, making hemolytic disease caused by other minor blood g roups more important. Kidd antigen is also known to cause hemolytic transfusion reactions. Only 13 cases have been reported so far, because Kidd antigen dose not usually cause HDN. Most cases have a good outcome, and only two fatal cases have been reported. A four-day-old male patient was hospitalized for jaundice, and hemolysis was confirmed by blood test. The mother’s blood was Jkb antibody positive. The patient did not improve with phototherapy, so an exchange transfusion was performed. Additional hemolysis occurred, so we undertook transfusion of red blood cells, resulting in cessation of hemolysis. We report HDN caused by Jkb antibody that responded to exchange blood transfusion.
Keywords: Hemolytic disease of the newborn, Jaundice, Exchange transfusion, Kidd blood group, Anti-Jkb
Introduction

Hemolytic disease of the newborn (HDN) is a state in which a maternal antibody passes through the placenta and destruction of red blood cells (RBC) of fetus or newborn [1]. Maternal antibodies are produced by homologous immune responses that are exposed through events such as transfusion or fetomaternal hemorrhage [1]. Hemolysis results in anemia, hyperbilirubinemia, thrombocytopenia, and leukopenia [2].

The most common cause of HDN is anti-RhD [1]. How-ever, with the use of immunoglobulins against RhD (RhoGAM) in 1965, its frequency is greatly reduced [2]. After introduction of RhD immunoprophylaxis, other antibodies to minor type of RBC antigens such as Kell, Duffy, and Kidd are considered to be the cause of hemolytic diseases [1,2].

In 1951, Kidd blood group, anti-Jka, was described by Allen et al. and 2 years later, Plaut et al. discovered anti-Jkb [3-5]. Anti-Jkb may cause severe hemolytic reaction in transfusion, but HDN by anti-Jkb usually had favorable prognosis [6].

The authors experienced a case of a newborn which was given an exchange transfusion due to hemolytic disease caused by anti-Jkb.

Case Report

A male patient was admitted for jaundice at the fourth day of born. He was delivered from a 33-year-old woman with gravida 2, para 1 at 38-weeks and 4-days gestation. The first baby had jaundice but did not need to treat. His mother had anti-Jkb confirmed by serum antibody screen-ing test at the second trimester of pregnancy. Any antibody was not found during the first pregnancy and the first trimester of second pregnancy. There were no history of transfusion and medication.

He had been fed formula milk and 60 to 70 mL every three hours. His icteric skin color was detected at the fourth day of birth, and he visited local hospital and checked total bilirubin level which was 23.1 mg/dL (Reference range: <18 mg/dL). He didn’t have splenomegaly and hepatomegaly. The laboratory data were shown as following at our hospital. The levels of hemoglobin, hematocrit and reticulocyte count were 13.0 g/dL, 39.0%, and 2.19%, respectively. Result of peripheral blood smear was normocytic normochromic RBCs, and WBC and platelet count were in within the normal limit. The result of direct antiglobulin test was IgG positive (2+), and indirect antiglobulin test negative. The results of aspartate transaminase (AST), alanine transaminase (ALT), total bilirubin, and direct bilirubin levels were 39 U/L, 16 U/L, 25.02 mg/dL, and 1.68 mg/dL, respectively. His blood type was A, RhD positive, and mother’s blood type was A, RhD positive, too. Irregular antibody was detected in his serum, but we could not identify a specific anti-body. It was only assumed that the irregular antibody was Jkb antibody because it was found in the mother’s blood (Table 1).

Table 1 . Summary of immune-hematologic data of patient and his mother.

 MotherPatient
ABOAA
Rh(D)PositivePositive
Direct Coomb’s test
IgGNot donePositive (2+)
C3dNot doneNegative
Antibody identificationAnti-JkbUnknown
Rh/Kell phenotypeNot doneC+, c−, E−, e+
Jk system phenotypeNot doneJkb positive


Although we immediately started intensive phototherapy and fluid therapy, the level of total bilirubin was elevated up to 30.2 mg/dL. We decided to do exchange transfusion for resolving hyperbilirubinemia avoiding kernicterus. Exchange transfusion was done successfully without complications. After exchange transfusion, total bilirubin level was decreased to 8.79 mg/dL. Blood tests were conducted on the next day and showed moderate anemia (hemoglobin 8.1 g/dL) and hyperbilirubinemia (total bilirubin 13.01 mg/dL). Irradiated and filtered RBC transfusion (10 mL/kg, over 3 hours) was carried out. He was subsequently discharged from the hospital after confirmed without further hemolytic reaction and hyperbilirubinemia (total bilirubin 6.0 mg/dL) on the 8th day of hospitalization. Auditory brainstem response was normal and brain MRI findings are a cystic change of germinal matrix hemorrhage grade I, which is thought to be rarely related with jaundice and exchange transfusion.

After discharge, IgG titer in direct antiglobulin test was monitored at outpatient department, which was decreased gradually and became negative for one month of age. 

Discussion

The International Society of Blood Transmission (ISBT) introduces a total of 36 blood group systems and 322 antigens [6]. Among them, Kidd blood group is the ninth [6]. The Kidd Blood group consists of three antigen, Jka, Jkb, and Jk3, with four phenotypes, Jk(a+b+), Jk(a-b+), Jk(a+b−), and Jk(a−b−) [5]. Antigens are located on the RBC’s urea transporter, UT-B glycoprotein [5]. Kidd glycoprotein as a urea transporter has no significant clinical significance, but only two cases have been reported that showed mild urine-concentrating defects in the Jk (a−b−) phenotype [5]. However, if an antibody is developed due to the sensitization of Kidd antigen, it is known that severe hemolytic transfusion reaction can occur [5]. Therefore, an antigen-negative RBC must be used for transfusions. However, even if antibodies are formed, it is difficult to detect because the antibody’s level decreases rapidly, so sensitive methods such as enzyme indirect antiglobulin tests may be required [5].

Most of the pathways exposed to Kidd antigen are transfusions and are known to cause immediate and delayed hemolytic transmission reactions during transfusions [6]. However, since the antibody is IgG, it can cross through the placenta and cause hemolysis, but it is known that it is rarely sensitized [5].

In this case, any antibodies were not identified during the first pregnancy and until the first trimester of the second pregnancy, but anti-Jkb was identified in the second trimester of that. The mother had no history of transfusion, and the path of antigen exposure from outside was unclear. Supposedly, the first baby had Jkb antigen positive RBC, and during pregnancy or delivery, the mother was sensitized by the first baby’s RBC to produce anti-Jkb. Antibody that formed during the first pregnancy was transmitted to the patient through the placenta, causing hemolysis. The irregular antibody identified in the serum of the patient is likely to be anti-Jkb delivered from the mother, but it did not be confirmed by laboratory test because of the characteristics of Kidd antibody which level is quickly reduced and difficult to detect [5]. It is assumed that jaundice in the first baby was also a weak antibody reaction. We also think that the analysis of the first baby’s RBC surface antigens is necessary to support the above. However mother didn’t want to take blood sample to detect the first baby’s phenotype. We just performed antigen tests attached to RBCs with the patient’s blood, and Jkb antigen was confirmed to be positive. Therefore, we were able to determine that the mother’s Jkb antibody was the cause of hemolysis in the patient (Table 1).

So far, only 13 cases of hemolysis have been reported in newborns by anti-Jkb [7]. Most of them improved with phototherapy or without treatment, but there were rare fatal cases (Table 2) [7-19]. In this case, there was no indication that the prepartum examination would suggest the hemolysis of the fetus, such as hydrops fetalis, fortunately. In addition, symptoms such as jaundice and anemia were not shown immediately after birth. But jaundice occurred from the fourth day of birth, and the exchange transfusion was carried out because it did not improve due to phototherapy. The past history of the mother’s exposure to Kidd antigen was not clear, but it was discovered incidentally on antibody screening test during second trimester of pregnancy. However jaundice and anemia symptoms were not prominent after birth, he was discharged without any special management on the 3rd day of birth. In order to prediction and early treatment of HDN, we recommend that a screening test of unexpected antibody for mother should be conducted thorough prepartum examination even if the mother does not have a special past history, especially the first baby had past medical history of neonatal jaundice. It is also necessary to clarify the etiology of neonatal jaundice excluding physiologic jaundice.

Table 2 . Summary of the clinical and laboratory findings in published case of hemolytic disease of the newborn due to anti-Jkb.

Kornstad et al. [8]Geczy
et al. [9]
Wagman et al. [10]Zodin
et al. [11]
Lange
et al. [12]
Kim et al. [13]Merlob
et al. [14]
Tomar
et al. [15]
Park
et al. [16]
Kim
et al. [17]
Ferrando et al. [18]Thakral
et al. [19]
Velasco
et al. [7]
Present case
GA (weeks)41Full-term37Full-termFull-term3838Full-term37+537+52537Full-term38+4
Onset of Jaundice (hours)4Early2EarlyNM244302496Birth10None96
Days of peak total bilirubin (day)2212132244NM225
Peak total bilirubin (mg/dL)10.394.98.4824.516.814.42446.1NM18.18.630.2
Hemoglobin (g/dL)1214.821.2NM1713.112.418.89.711.4NMNM12.38.1
Hematocrit (%)NMNM6160.5NM3937.4NM28.136.8NM5037.123.8
Reticulocyte (%)6.44.6NMNMNM5.86.76514.9NM10.42NM2.19
TreatmentNoneNoneNoneNoneNonePTPT+TFNMPTPT+ETFTFPTNonePT+ETF+TF
OutcomeGoodGoodGoodGoodGoodGoodGoodGoodGoodFatalFatalGoodGoodGood
Gravida-para5-42-13-35-4NM1-03-34-32-14-24-37-03-32-1
Previous HDN siblings2nd childNoneNMNoneNMNone2nd childNoneSuspected 1st childSuspected 1st and 2nd childNoneSuspected 1stNoneSuspected 1st child

PT, phototherapy; ETF, exchange transfusion; TF, transfusion; NM, not mentioned..


Conflict of Interest Statement

The authors have no conflict of interest to declare.

References
  1. Moise KJ Jr. Changing trends in the management of red blood cell alloimmunization in pregnancy. Arch Pathol Lab Med 1994;118:421-8.
    Pubmed
  2. Rath ME, Smits-Wintjens VE, Walther FJ, Lopriore E. Hemato-logical morbidity and management in neonates with hemolytic disease due to red cell alloimmunization. Early Hum Dev 2011;87:583-8.
    Pubmed CrossRef
  3. Allen FH, Diamond LK, Niedziela B. A new blood-group antigen. Nature 1951;167:482.
    Pubmed KoreaMed CrossRef
  4. Plaut G, Ikin EW, Mourant AE, Sanger R, Race RR. A new blood-group antibody, anti-Jkb. Nature 1953;171:431.
    Pubmed CrossRef
  5. Lawicki S, Covin RB, Powers AA. The Kidd (JK) blood group system. Transfus Med Rev 2017;31:165-72.
    Pubmed CrossRef
  6. Thornton NM, Grimsley SP. Clinical significance of antibodies to antigens in the ABO, MNS, P1PK, Rh, Lutheran, Kell, Lewis, Duffy, Kidd, Diego, Yt, and Xg blood group systems. Immunohematology 2019;35:95-101.
    Pubmed CrossRef
  7. Velasco Rodríguez D, Pérez-Segura G, Jiménez-Ubieto A, Rodríguez MA, Montejano L. Hemolytic disease of the newborn due to anti-jkb: case report and review of the literature. Indian J Hematol Blood Transfus 2014;30:135-8.
    Pubmed KoreaMed CrossRef
  8. Kornstad L, Halvorsen K. Haemolytic disease of the newborn caused by anti-Jk b. Vox Sang 1958;3:94-9.
    Pubmed CrossRef
  9. Geczy A, Eslie M. Second example of hemolytic disease of the newborn caused by anti-Jk-b. Transfusion 1961;1:125-7.
    Pubmed CrossRef
  10. Wagman E, Bove JR. Anti-Jk-b. Hemolytic disease of the newborn caused by anti-Jk-b. Am J Clin Pathol 1964;41:481-3.
    Pubmed CrossRef
  11. Zodin V, Anderson RE. Hemolytic disease of the newborn due to anti-Kidd (Jkb): case report and review of the literature. Pediatrics 1965;36:420-2.
    Pubmed
  12. Lange MM, Lumare A, Corsi C. Hemolytic disease of the newborn caused by anti-Jkb antibody. Case report. Minerva Pediatr 1974;26:1765-7.
    Pubmed
  13. Kim HO, Kwon OH, Lee SY, Lee YS, Kim SK. A case of hemolytic disease of the newborn due to anti-Jkb. Korean J Hematol 1986;21:319-22.
  14. Merlob P, Litwin A, Reisner SH, Cohen IJ, Zaizov R. Hemolytic disease of the newborn caused by anti-Jkb. Pediatr Hematol Oncol 1987;4:357-60.
    Pubmed CrossRef
  15. Tomar V, Dhingra N, Madan N, Faridi MM. Hemolytic disease of the newborn due to maternal anti-Kidd (anti-Jkb). Indian Pediatr 1998;35:1251-3.
    Pubmed
  16. Park DK, Kim YM, Bae CW, Choi YM, Lee WI. A case of hemolytic disease in a newborn due to anti-Jkb. J Korean Pediatr Soc 2003;46:718-21.
  17. Kim WD, Lee YH. A fatal case of severe hemolytic disease of newborn associated with anti-Jk(b). J Korean Med Sci 2006;21:151-4.
    Pubmed KoreaMed CrossRef
  18. Ferrando M, Martínez-Cañabate S, Luna I, et al. Severe hemolytic disease of the fetus due to anti-Jkb. Transfusion 2008;48:402-4.
    Pubmed CrossRef
  19. Thakral B, Malhotra S, Saluja K, Kumar P, Marwaha N. He-molytic disease of newborn due to anti-Jk b in a woman with high risk pregnancy. Transfus Apher Sci 2010;43:41-3.
    Pubmed CrossRef


April 2021, 28 (1)
Full Text PDF
Citation
Send to a friend
Twitter
Facebook

Cited By Articles
  • CrossRef (0)

Author ORCID Information
  • Mee Jeong Lee